Neurotech Pharmaceuticals, Inc.: FDA Greenlights Mazzo's Neurotech Implant

Neurotech Pharmaceuticals Inc.'s research efforts are paying off. The biotech company, focused on developing treatments for chronic eye conditions, received Food and Drug Administration (FDA) approval this month for its cell therapy implant Encelto. The implant could treat idiopathic macular telangiectasia (MacTel) type 2 in adults, a rare neurodegenerative eye disease causing progressive vision loss. [...] The post FDA Greenlights Mazzo's Neurotech Implant appeared first on Orange County Business Journal.